JP2010105968A5 - - Google Patents

Download PDF

Info

Publication number
JP2010105968A5
JP2010105968A5 JP2008281065A JP2008281065A JP2010105968A5 JP 2010105968 A5 JP2010105968 A5 JP 2010105968A5 JP 2008281065 A JP2008281065 A JP 2008281065A JP 2008281065 A JP2008281065 A JP 2008281065A JP 2010105968 A5 JP2010105968 A5 JP 2010105968A5
Authority
JP
Japan
Prior art keywords
mucosal
vaccine preparation
administration according
intranasal administration
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008281065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010105968A (ja
JP5344558B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2008281065A external-priority patent/JP5344558B2/ja
Priority to JP2008281065A priority Critical patent/JP5344558B2/ja
Priority to EP09823688.8A priority patent/EP2345419B8/en
Priority to US13/126,357 priority patent/US20110206729A1/en
Priority to PCT/JP2009/068647 priority patent/WO2010050578A1/ja
Priority to ES09823688.8T priority patent/ES2624722T3/es
Publication of JP2010105968A publication Critical patent/JP2010105968A/ja
Publication of JP2010105968A5 publication Critical patent/JP2010105968A5/ja
Publication of JP5344558B2 publication Critical patent/JP5344558B2/ja
Application granted granted Critical
Priority to US14/478,127 priority patent/US8961983B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008281065A 2008-10-31 2008-10-31 カチオン性ナノゲルを用いる粘膜ワクチン Active JP5344558B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2008281065A JP5344558B2 (ja) 2008-10-31 2008-10-31 カチオン性ナノゲルを用いる粘膜ワクチン
ES09823688.8T ES2624722T3 (es) 2008-10-31 2009-10-30 Vacuna mucosa que emplea nanogel catiónico
US13/126,357 US20110206729A1 (en) 2008-10-31 2009-10-30 Mucosal vaccine using cationic nanogel
PCT/JP2009/068647 WO2010050578A1 (ja) 2008-10-31 2009-10-30 カチオン性ナノゲルを用いる粘膜ワクチン
EP09823688.8A EP2345419B8 (en) 2008-10-31 2009-10-30 Mucosal vaccine using cationic nanogel
US14/478,127 US8961983B2 (en) 2008-10-31 2014-09-05 Mucosal vaccine using cationic nanogel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008281065A JP5344558B2 (ja) 2008-10-31 2008-10-31 カチオン性ナノゲルを用いる粘膜ワクチン

Publications (3)

Publication Number Publication Date
JP2010105968A JP2010105968A (ja) 2010-05-13
JP2010105968A5 true JP2010105968A5 (https=) 2011-11-24
JP5344558B2 JP5344558B2 (ja) 2013-11-20

Family

ID=42128937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008281065A Active JP5344558B2 (ja) 2008-10-31 2008-10-31 カチオン性ナノゲルを用いる粘膜ワクチン

Country Status (5)

Country Link
US (2) US20110206729A1 (https=)
EP (1) EP2345419B8 (https=)
JP (1) JP5344558B2 (https=)
ES (1) ES2624722T3 (https=)
WO (1) WO2010050578A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100215582A1 (en) * 2007-05-14 2010-08-26 Konica Minolta Holdings, Inc. Liposome and method for producing liposome
JP5344558B2 (ja) 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン
PH12012500549A1 (en) 2009-10-21 2017-08-23 Revance Therapeutics Inc Methods and systems for purifying non-complexed botulinum neurotoxin
PT2663294E (pt) 2011-01-11 2016-01-25 Capsugel Belgium Nv Novas cápsulas duras contendo pululano
US10047116B2 (en) * 2011-10-03 2018-08-14 Mx Adjuvac Ab Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
WO2013085021A1 (ja) * 2011-12-09 2013-06-13 株式会社林原 抗体産生増強用の組成物
JP6310720B2 (ja) * 2014-02-17 2018-04-11 知的財産戦略ネットワーク株式会社 肺炎球菌経鼻ワクチン
EP3153175B1 (en) * 2014-06-04 2019-08-07 Osaka University Adjuvant for mucosal vaccine
US20170319706A1 (en) * 2014-11-18 2017-11-09 Dow Global Technologies Llc Delivering a drug to a mucosal surface
JP7246644B2 (ja) 2016-12-03 2023-03-28 ザ ユーエービー リサーチ ファウンデイション 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
CN107583059B (zh) * 2017-10-31 2021-03-30 宁夏医科大学 一种可包载量子点的阳离子脂质体流感疫苗及其制备方法
WO2020027309A1 (ja) * 2018-08-03 2020-02-06 国立大学法人東京大学 細胞性免疫を誘導する経鼻ワクチン
JP2020019754A (ja) * 2018-08-03 2020-02-06 国立研究開発法人農業・食品産業技術総合研究機構 ウシ乳房炎に対する粘膜ワクチン組成物
JPWO2022210465A1 (https=) * 2021-03-30 2022-10-06
WO2023107951A1 (en) 2021-12-08 2023-06-15 Immunitybio, Inc. Neoepitope vaccine delivery vehicle and methods of making the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63270555A (ja) 1987-04-28 1988-11-08 日鉄鉱業株式会社 ロ−ルクラツシヤ
JPH05339169A (ja) 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
US6967088B1 (en) * 1995-03-16 2005-11-22 Allergan, Inc. Soluble recombinant botulinum toxin proteins
WO1998009650A1 (en) * 1996-09-06 1998-03-12 Mitsubishi Chemical Corporation Vaccinal preparations
WO2000012564A1 (en) 1998-08-31 2000-03-09 Nof Corporation High-purity polysaccharide containing hydrophobic groups and process for producing the same
JP4599550B2 (ja) 2004-04-09 2010-12-15 国立大学法人 東京医科歯科大学 ナノゲル工学によるハイブリッドゲルの調製とバイオマテリアル応用
WO2006049032A1 (ja) 2004-11-01 2006-05-11 Tokyo Medical And Dental University ナノゲル－アパタイト複合体の調製
JP4550555B2 (ja) 2004-11-17 2010-09-22 国立大学法人 東京医科歯科大学 量子ドット（Ｑｄｏｔ）−ナノゲル複合体の調製
EP1974754A4 (en) 2006-01-18 2012-09-05 Nat Univ Corp Tokyo Med & Dent BIOMATERIAL FOR OSTEOGENESIS CONTAINING A PROMOTER OF OSTEOGENESIS AND A NANOGEL
JP2007252304A (ja) * 2006-03-24 2007-10-04 Tokyo Medical & Dental Univ ナノゲルを用いたタンパク質の細胞内導入法
JP5428017B2 (ja) * 2007-03-23 2014-02-26 国立大学法人 熊本大学 ワクチン剤
JP2008281065A (ja) 2007-05-09 2008-11-20 Nsk Ltd 玉軸受
GB0717864D0 (en) * 2007-09-13 2007-10-24 Peptcell Ltd Peptide sequences and compositions
JP5344558B2 (ja) 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン

Similar Documents

Publication Publication Date Title
JP2010105968A5 (https=)
CN107961374B (zh) 疫苗组合物
Riese et al. Intranasal formulations: promising strategy to deliver vaccines
Nian et al. Development of nasal vaccines and the associated challenges
MY180698A (en) Immunization protocol against the 4 dengue serotypes
JP2015535259A5 (https=)
BRPI0212999B8 (pt) novas composições imunogênicas para a prevenção e tratamento de doença meningocócica
TR201900418T4 (tr) Pnömokok polisakkarit konjugat aşısı.
JP2005511662A5 (https=)
NO20082149L (no) Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for bruk
CN108434089A (zh) 使用淀粉的口服疫苗快速溶解剂型
Klein et al. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines
Wei et al. Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
JP6494233B2 (ja) 粘膜ワクチン組成物
JP2009514840A5 (https=)
Nordin et al. Natural polymeric composites derived from animals, plants, and microbes for vaccine delivery and adjuvant applications: A review
Kieny et al. Research and development of new vaccines against infectious diseases
NZ603854A (en) West nile virus vaccine
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
JP6494232B2 (ja) 粘膜ワクチン組成物
WO2023147337A3 (en) Large-scale flaviviral vaccine production and manufacture
Li et al. Self-assembled proteinaceous nanoparticles for co-delivery of antigens and cytosine phosphoguanine (CpG) adjuvants: implications for nanovaccines
JP2023091085A (ja) 粘膜アジュバント
JP4554268B2 (ja) 分泌型ＩｇＡ抗体誘導剤